Literature DB >> 1900690

Restricted diversity of the variable region nucleotide sequences of the heavy and light chains of a human rheumatoid factor.

I Ezaki1, H Kanda, K Sakai, N Fukui, M Shingu, M Nobunaga, T Watanabe.   

Abstract

The complete nucleotide sequences of the variable region genes of the heavy and light polypeptide chains of a human monoclonal rheumatoid factor (RF) produced from a human-mouse heterohybridoma were determined. The antibody, designated YES8c, contained V kappa III, J kappa 2, VH1, JH4, and a D gene segment of 9 amino acids. The nucleotide sequences and the deduced amino acid sequences of the light chain variable region were remarkably homologous (97-98%) to previously described RF of the Wa idiotypic family (PAY, GLO, CUR, FLO, and GAR) and to that of a V kappa III germline gene (Humkv325). The YES8c heavy chain variable region gene was most closely related to the VH1 gene of the restricted human fetal repertoire, designated 51p1, and also to 3 rearranged VH1 genes that were recently isolated from patients with chronic lymphocytic leukemia. These results suggest that variable region genes of RFs are highly conserved and that YES8c VH, as well as V kappa, may be identical to heavy and light chains expressed during early B cell development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900690     DOI: 10.1002/art.1780340312

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Sequence analyses of three immunoglobulin G anti-virus antibodies reveal their utilization of autoantibody-related immunoglobulin Vh genes, but not V lambda genes.

Authors:  D F Huang; T Olee; Y Masuho; Y Matsumoto; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Molecular analysis of rheumatoid factor (RF)-negative B cell hybridomas from rheumatoid synovial tissue: evidence for an antigen-induced stimulation with selection of high mutated IgVH and low mutated IgVL/lambda genes.

Authors:  V Krenn; A König; F Hensel; C Berek; M M Souto Carneiro; W Haedicke; Y Wang; H Vollmers; H K Müller-Hermelink
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium.

Authors:  B E Clausen; S L Bridges; J C Lavelle; P G Fowler; S Gay; W J Koopman; H W Schroeder
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

Review 4.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

5.  Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity.

Authors:  Mitsunori Shiroishi; Yuji Ito; Kenta Shimokawa; Jae Man Lee; Takahiro Kusakabe; Tadashi Ueda
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

6.  A somatically mutated V kappa IV gene encoding a human rheumatoid factor light chain.

Authors:  A Gause; R Küppers; R Mierau
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

7.  Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.

Authors:  M Børretzen; I Randen; E Zdárský; O Førre; J B Natvig; K M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.

Authors:  M M Newkirk; J Rauch
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

9.  Defining the genetic origins of three rheumatoid synovium-derived IgG rheumatoid factors.

Authors:  M Deftos; T Olee; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals.

Authors:  S L Bridges; S K Lee; M L Johnson; J C Lavelle; P G Fowler; W J Koopman; H W Schroeder
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.